Congressional Leaders Ask FDA About Coumadin Safety

The bipartisan leadership of the House Energy and Commerce Committee is asking the Food and Drug Administration how it monitors the safety of the popular blood thinner Coumadin, particularly in light of deaths and hospitalizations of nursing home residents taking the drug.

The full story can be read HERE. The Committee’s letter can be read HERE.

By | 2017-03-15T20:53:29+00:00 September 11th, 2015|Blog|Comments Off on Congressional Leaders Ask FDA About Coumadin Safety